Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Wayland Group Corp. MRRCF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Wayland Group Corp. (MRRCF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 17/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $2M, -19%/yr average growth. Net income is $52M (loss), growing at -4622%/yr. Net profit margin is -2079.4% (negative). Gross margin is -154.9% (-109.5 pp trend).

Balance sheet: total debt is $19M against $49M equity (Debt-to-Equity (D/E) ratio 0.38, conservative). Current ratio is 3.9 (strong liquidity). Debt-to-assets is 25.1%. Total assets: $74M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

MRRCF SharesGrow Score Overview

31/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MRRCF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
MRRCF: -19%/yr revenue is, -4622%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet MRRCF: Debt-to-Equity (D/E) ratio 0.38 (conservative), Current ratio is 3.9 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
MRRCF: Net profit margin is -2079.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume200
Avg Volume (30D)1.64K
Market Cap$2.12K
Beta (1Y)-44.34
Share Statistics
EPS (TTM)-0.75
Shares Outstanding$68.88M
IPO Date2001-05-07
Employees68
CEODavid Miller
Financial Highlights & Ratios
Revenue (TTM)$2.48M
Gross Profit$-3.85M
EBITDA$-50.22M
Net Income$-51.63M
Operating Income$-21.32M
Total Cash$19.61M
Total Debt$18.7M
Net Debt$-917.01K
Total Assets$74.49M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA9442041062

Price Chart

Track all markets on TradingView
MRRCF
Wayland Group Corp. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

APNHF
APNHF
Aspen Pharmacare Holdings Limited
$8.69
+0.00%
 ATHJF
ATHJF
Antisense Therapeutics Limited
$0.01
-76.00%
 MEDIF
MEDIF
MediPharm Labs Corp.
$0.05
+0.28%
 AVCNF
AVCNF
Avicanna Inc.
$0.12
+3.42%
 MVMDF
MVMDF
Mountain Valley MD Holdings Inc.
$0.04
+8.40%
 BCBCF
BCBCF
The BC Bud Corporation
$0.04
-3.31%
 UBQU
UBQU
Ubiquitech Software Corp.
$0.00
+0.00%
 ANTCF
ANTCF
Aion Therapeutic Inc.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message